You just read:

FDA Approves Merz Pharmaceuticals' Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm

News provided by

Merz Pharmaceuticals, LLC

Aug 02, 2010, 08:11 ET